BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27555294)

  • 1. Asparaginase-associated pancreatitis is not predicted by hypertriglyceridemia or pancreatic enzyme levels in children with acute lymphoblastic leukemia.
    Raja RA; Schmiegelow K; Sørensen DN; Frandsen TL
    Pediatr Blood Cancer; 2017 Jan; 64(1):32-38. PubMed ID: 27555294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial Ultrasound Monitoring for Early Recognition of Asparaginase Associated Pancreatitis in Children With Acute Lymphoblastic Leukemia.
    Raja RA; Schmiegelow K; Henriksen BM; Leth Frandsen T
    Pediatr Hematol Oncol; 2015; 32(7):474-81. PubMed ID: 26270775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol.
    Raja RA; Schmiegelow K; Albertsen BK; Prunsild K; Zeller B; Vaitkeviciene G; Abrahamsson J; Heyman M; Taskinen M; Harila-Saari A; Kanerva J; Frandsen TL;
    Br J Haematol; 2014 Apr; 165(1):126-33. PubMed ID: 24428625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents.
    Persson L; Harila-Saari A; Hed Myrberg I; Heyman M; Nilsson A; Ranta S
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28440015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia.
    Finch ER; Smith CA; Yang W; Liu Y; Kornegay NM; Panetta JC; Crews KR; Molinelli AR; Cheng C; Pei D; Ramsey LB; Karol SE; Inaba H; Sandlund JT; Metzger M; Evans WE; Jeha S; Pui CH; Relling MV
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28040. PubMed ID: 31612640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age.
    Rank CU; Wolthers BO; Grell K; Albertsen BK; Frandsen TL; Overgaard UM; Toft N; Nielsen OJ; Wehner PS; Harila-Saari A; Heyman MM; Malmros J; Abrahamsson J; Norén-Nyström U; Tomaszewska-Toporska B; Lund B; Jarvis KB; Quist-Paulsen P; Vaitkevičienė GE; Griškevičius L; Taskinen M; Wartiovaara-Kautto U; Lepik K; Punab M; Jónsson ÓG; Schmiegelow K
    J Clin Oncol; 2020 Jan; 38(2):145-154. PubMed ID: 31770057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreas-related persisting sequelae in ALL survivors with a history of asparaginase-associated pancreatitis: A part of the ALL-STAR study.
    Skipper MT; Birkebæk N; Jensen RB; Rank CU; Tuckuviene R; Wehner PS; Lambine TL; Hørlyck A; Schmiegelow K; Frandsen TL; Andrés-Jensen L; Albertsen BK
    Eur J Haematol; 2024 Jun; 112(6):944-956. PubMed ID: 38351310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience in diagnosis and treatment of asparaginase-associated pancreatitis in children].
    Chen Z; Li J
    Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):854-8. PubMed ID: 25582474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
    Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
    Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study.
    Wolthers BO; Frandsen TL; Baruchel A; Attarbaschi A; Barzilai S; Colombini A; Escherich G; Grell K; Inaba H; Kovacs G; Liang DC; Mateos M; Mondelaers V; Möricke A; Ociepa T; Samarasinghe S; Silverman LB; van der Sluis IM; Stanulla M; Vrooman LM; Yano M; Zapotocka E; Schmiegelow K;
    Lancet Oncol; 2017 Sep; 18(9):1238-1248. PubMed ID: 28736188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.
    Morimoto A; Imamura T; Ishii R; Nakabayashi Y; Nakatani T; Sakagami J; Yamagami T
    Cancer; 2008 Sep; 113(6):1362-9. PubMed ID: 18661511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol.
    Wolthers BO; Frandsen TL; Abrahamsson J; Albertsen BK; Helt LR; Heyman M; Jónsson ÓG; Kõrgvee LT; Lund B; Raja RA; Rasmussen KK; Taskinen M; Tulstrup M; Vaitkevičienė GE; Yadav R; Gupta R; Schmiegelow K
    Leukemia; 2017 Feb; 31(2):325-332. PubMed ID: 27451978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
    Wu SF; Chen AC; Peng CT; Wu KH
    Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia.
    Sahu S; Saika S; Pai SK; Advani SH
    Pediatr Hematol Oncol; 1998; 15(6):533-8. PubMed ID: 9842647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
    Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Asparaginase and steroids-associated hypertriglyceridemia successfully treated with plasmapheresis in a child with acute lymphoblastic leukemia.
    Solano-Páez P; Villegas JA; Colomer I; Gutierrez MD; Fernandez-Teijeiro A
    J Pediatr Hematol Oncol; 2011 Apr; 33(3):e122-4. PubMed ID: 21399528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum trypsin and elastase-1 levels in patients undergoing L-asparaginase therapy.
    Shimizu T; Yamashiro Y; Igarashi J; Fujita H; Ishimoto K
    Eur J Pediatr; 1998 Jul; 157(7):561-3. PubMed ID: 9686816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study.
    Albertsen BK; Grell K; Abrahamsson J; Lund B; Vettenranta K; Jónsson ÓG; Frandsen TL; Wolthers BO; Heyman M; Schmiegelow K
    J Clin Oncol; 2019 Jul; 37(19):1638-1646. PubMed ID: 30978155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
    Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical analysis of asparaginase-associated pancreatitis in children.
    Du X; Liu Z; Jia X; Wen Y; Tang Y; Xu X; Jiang M
    Pancreatology; 2022 Sep; 22(6):706-712. PubMed ID: 35718704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.